Titre : Belize

Belize : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Belize : Questions médicales les plus fréquentes", "headline": "Belize : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Belize : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-18", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Belize" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Amérique centrale", "url": "https://questionsmedicales.fr/mesh/D002489", "about": { "@type": "MedicalCondition", "name": "Amérique centrale", "code": { "@type": "MedicalCode", "code": "D002489", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.107.169" } } }, "about": { "@type": "MedicalCondition", "name": "Belize", "alternateName": "Belize", "code": { "@type": "MedicalCode", "code": "D001531", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Francis Morey", "url": "https://questionsmedicales.fr/author/Francis%20Morey", "affiliation": { "@type": "Organization", "name": "Ministry of Health and Wellness, Belmopan, Belize." } }, { "@type": "Person", "name": "Natalia Largaespada Beer", "url": "https://questionsmedicales.fr/author/Natalia%20Largaespada%20Beer", "affiliation": { "@type": "Organization", "name": "Ministry of Health and Wellness, Belize." } }, { "@type": "Person", "name": "Russell Manzanero", "url": "https://questionsmedicales.fr/author/Russell%20Manzanero", "affiliation": { "@type": "Organization", "name": "Belize Ministry of Health and Wellness, East Block Building, National Assembly, Bliss Parade, Belmopan, Belize." } }, { "@type": "Person", "name": "Kristy O Murray", "url": "https://questionsmedicales.fr/author/Kristy%20O%20Murray", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine and Texas Children's Hospital, 1102 Bates Ave, Houston, TX 77030, USA." } }, { "@type": "Person", "name": "John P Grieco", "url": "https://questionsmedicales.fr/author/John%20P%20Grieco", "affiliation": { "@type": "Organization", "name": "Eck Institute of Global Health, University of Notre Dame, 120 Brown Hall, Notre Dame, IN 46556, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36651430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/acb371205" } }, { "@type": "ScholarlyArticle", "name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36253300", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clgc.2022.09.007" } }, { "@type": "ScholarlyArticle", "name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.", "datePublished": "2024-10-20", "url": "https://questionsmedicales.fr/article/39428439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-76355-4" } }, { "@type": "ScholarlyArticle", "name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37271051", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cmpb.2023.107624" } }, { "@type": "ScholarlyArticle", "name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36917412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03531-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Amériques", "item": "https://questionsmedicales.fr/mesh/D000569" }, { "@type": "ListItem", "position": 4, "name": "Amérique centrale", "item": "https://questionsmedicales.fr/mesh/D002489" }, { "@type": "ListItem", "position": 5, "name": "Belize", "item": "https://questionsmedicales.fr/mesh/D001531" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Belize - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Belize", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Belize", "description": "Comment diagnostiquer le paludisme à Belize ?\nQuels tests pour la dengue à Belize ?\nComment identifier une infection parasitaire ?\nQuels signes indiquent une tuberculose ?\nComment diagnostiquer le VIH à Belize ?", "url": "https://questionsmedicales.fr/mesh/D001531?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Belize", "description": "Quels sont les symptômes de la malaria ?\nQuels symptômes de la dengue ?\nComment reconnaître une infection respiratoire ?\nQuels signes d'une infection intestinale ?\nQuels symptômes de la tuberculose ?", "url": "https://questionsmedicales.fr/mesh/D001531?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Belize", "description": "Comment prévenir le paludisme ?\nQuelles mesures pour éviter la dengue ?\nComment prévenir les infections respiratoires ?\nQuelles précautions pour les infections intestinales ?\nComment prévenir la tuberculose ?", "url": "https://questionsmedicales.fr/mesh/D001531?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Belize", "description": "Quel traitement pour le paludisme ?\nComment traiter la dengue ?\nQuel traitement pour la tuberculose ?\nComment traiter une infection parasitaire ?\nQuel est le traitement du VIH ?", "url": "https://questionsmedicales.fr/mesh/D001531?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Belize", "description": "Quelles complications du paludisme ?\nQuelles complications de la dengue ?\nQuelles complications de la tuberculose ?\nQuelles complications des infections intestinales ?\nQuelles complications du VIH ?", "url": "https://questionsmedicales.fr/mesh/D001531?mesh_terms=Prostatic+Neoplasms&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Belize", "description": "Quels sont les facteurs de risque du paludisme ?\nQuels facteurs augmentent le risque de dengue ?\nQuels sont les facteurs de risque de tuberculose ?\nQuels facteurs de risque pour les infections intestinales ?\nQuels facteurs de risque pour le VIH ?", "url": "https://questionsmedicales.fr/mesh/D001531?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le paludisme à Belize ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par un test sanguin pour détecter le parasite du paludisme." } }, { "@type": "Question", "name": "Quels tests pour la dengue à Belize ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et PCR sont utilisés pour confirmer une infection par le virus de la dengue." } }, { "@type": "Question", "name": "Comment identifier une infection parasitaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un examen des selles et des tests sanguins peuvent aider à identifier les infections parasitaires." } }, { "@type": "Question", "name": "Quels signes indiquent une tuberculose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "La toux persistante, la fièvre et la perte de poids sont des signes de tuberculose." } }, { "@type": "Question", "name": "Comment diagnostiquer le VIH à Belize ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic du VIH se fait par des tests sanguins spécifiques, comme le test ELISA." } }, { "@type": "Question", "name": "Quels sont les symptômes de la malaria ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont courants." } }, { "@type": "Question", "name": "Quels symptômes de la dengue ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, douleurs articulaires, éruptions cutanées et fatigue intense." } }, { "@type": "Question", "name": "Comment reconnaître une infection respiratoire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Toux, essoufflement, douleur thoracique et fièvre sont des indicateurs clés." } }, { "@type": "Question", "name": "Quels signes d'une infection intestinale ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Diarrhée, douleurs abdominales, nausées et vomissements sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes de la tuberculose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, crachats sanguinolents, fièvre et sueurs nocturnes." } }, { "@type": "Question", "name": "Comment prévenir le paludisme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires, des répulsifs et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la dengue ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des insecticides pour réduire les moustiques." } }, { "@type": "Question", "name": "Comment prévenir les infections respiratoires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter les contacts avec des personnes malades." } }, { "@type": "Question", "name": "Quelles précautions pour les infections intestinales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Boire de l'eau potable et éviter les aliments crus ou mal cuits." } }, { "@type": "Question", "name": "Comment prévenir la tuberculose ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Vaccination et dépistage précoce des personnes à risque sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour le paludisme ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antipaludiques comme la chloroquine et l'artémisinine sont utilisés." } }, { "@type": "Question", "name": "Comment traiter la dengue ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique, mais le repos et l'hydratation sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour la tuberculose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement antibiotique prolongé est nécessaire, souvent pendant six mois." } }, { "@type": "Question", "name": "Comment traiter une infection parasitaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des antiparasitaires spécifiques sont prescrits selon le type d'infection." } }, { "@type": "Question", "name": "Quel est le traitement du VIH ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie antirétrovirale (TAR) est essentielle pour gérer le VIH." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Anémie sévère, défaillance organique et coma peuvent survenir sans traitement." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La dengue sévère peut entraîner des hémorragies et un choc hypovolémique." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La tuberculose peut causer des lésions pulmonaires permanentes et la dissémination." } }, { "@type": "Question", "name": "Quelles complications des infections intestinales ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation sévère et les infections systémiques peuvent survenir." } }, { "@type": "Question", "name": "Quelles complications du VIH ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le VIH peut entraîner des infections opportunistes et des cancers associés." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du paludisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones endémiques et ne pas utiliser de protection contre les moustiques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de dengue ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "La proximité des eaux stagnantes et le manque de contrôle des moustiques sont des risques." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de tuberculose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Conditions de vie surpeuplées et immunodépression augmentent le risque d'infection." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les infections intestinales ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Consommation d'eau contaminée et mauvaise hygiène alimentaire sont des risques majeurs." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le VIH ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les comportements à risque, comme le partage de seringues, augmentent le risque d'infection." } } ] } ] }

Sources (10000 au total)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy.

Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat... Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus.... Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ... There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....

Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.

In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals.... This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ... It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high... As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...

Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.

With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di... We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ... An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve... This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.

To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n... The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit... In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ... A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.

Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o... PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u... More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ... Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....

Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?

Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga... Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu... Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114... The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...